Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Endorotor versus standard endoscopic removal for walled-off pancreatic necrosis

Official title: Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis

Run by Assistance Publique - Hôpitaux de Paris · NCT07253350 · Data updated 2026-11-12

This trial will try whether using the Endorotor device helps adults with infected or symptomatic walled-off pancreatic necrosis recover faster or with fewer procedures than standard endoscopic necrosectomy after drainage.

More Acute Necrotizing Pancreatitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment64 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Clichy)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedMarch 2029
Study endsNovember 2029
Registry record updatedJanuary 30, 2026
Trial IDNCT07253350 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) hospitalized for acute necrotizing pancreatitis who have undergone endoscopic drainage for infected or symptomatic WON and still require at least one DEN session are ideal candidates.

Probably not a fit

Patients without an endoscopic drainage in place, those who already had a necrosectomy before screening, people with limited life expectancy, known major bleeding disorders, or who are pregnant will not benefit or are ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a national, single-blinded, multicenter randomized (1:1) trial using a PROBE design that enrolls adults with complicated acute necrotizing pancreatitis who require direct endoscopic necrosectomy (DEN) after endoscopic drainage of walled-off necrosis (WON). Participants are randomized to conventional DEN or DEN using the Endorotor system, with outcomes including clinical recovery, number of necrosectomy sessions, complications, and cost-utility. Informed consent is obtained after at least 24 hours of consideration following a minimum 48-hour interval from drainage to the first necrosectomy session. The trial compares procedural effectiveness and resource use between the two approaches across participating French centers.

Why it matters

Potential benefit: If successful, the Endorotor approach could reduce the number of necrosectomy sessions, shorten hospital stays, lower complication rates, and decrease overall treatment costs.

How similar studies have gone: Small case series and nonrandomized reports of powered endoscopic necrosectomy devices have shown promising results, but randomized controlled evidence directly comparing Endorotor to conventional DEN is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age≥18years
* ASA\<5
* CT scan less than 7 days old
* Hospitalized for acute necrotizing pancreatitis, whatever the cause, and who have undergone drainage of pancreatic collections for the following indications according to the revised Atlanta criteria (infection, organ compression, persistent organ failure)
* Have need for at least one DEN session despite endoscopic drainage (persistence of clinical symptoms or sepsis \>48h after drainage with collection still visible)

Exclusion Criteria:

* No endoscopic drainage in place for the management of WON
* Have already had a DEN session (endoscopic or else) before screening for inclusion
* Life-expectancy \< 1year (advanced cancer, etc)
* Known haemostasis disorder (chronic thrombocytopenia, haemophilia, etc.)
* Pregnant or breastfeeding woman
* Subject deprived of freedom, subject under a legal protective measure
* Non-affiliation to a social security regimen or CMU
* Patient or person of confidence (if present at the time of inclusion) opposing the patient's participation in research
* Subject already involved in another interventional clinical research

Where it's running

  • Hospital Beaujon, APHP
    Clichy, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.